1. Search Result
Search Result
Results for "

Arabinose

" in MedChemExpress (MCE) Product Catalog:

30

Inhibitors & Agonists

4

Biochemical Assay Reagents

10

Natural
Products

5

Recombinant Proteins

11

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N2353

    (±)​-​Arabinose; DL-​Arabinose; dl-​Arabinose

    Endogenous Metabolite Metabolic Disease
    Arabinose is a 5-carbon sugar often found in plants. Arabinose is chiral diastereomer that exhibits specific crystallization behavior. Arabinose can be used as excipients or cocrystallization agents in pharmaceutical formulations. Arabinose is an intermediate for drug synthesis .
    Arabinose
  • HY-N0059

    Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose
  • HY-N2353S1

    (±)​-​Arabinose-d; DL-​Arabinose-d

    Isotope-Labeled Compounds Endogenous Metabolite Others
    Arabinose-d is the deuterium labeled Arabinose. Arabinose is an endogenous metabolite .
    Arabinose-d1
  • HY-N2353S2

    (±)​-​Arabinose-d-1; DL-​Arabinose-d-1

    Isotope-Labeled Compounds Endogenous Metabolite Others
    Arabinose-d-1 is the deuterium labeled Arabinose. Arabinose is an endogenous metabolite .
    Arabinose-d1-1
  • HY-N2353R

    Endogenous Metabolite Metabolic Disease
    Arabinose (Standard) is the analytical standard of Arabinose. This product is intended for research and analytical applications. Arabinose is an endogenous metabolite.
    Arabinose (Standard)
  • HY-N2353S

    (±)​-​Arabinose-1-13C; DL-​Arabinose-1-13C

    Isotope-Labeled Compounds Endogenous Metabolite Others
    Arabinose-1- 13C is the 13C labeled Arabinose. Arabinose is an endogenous metabolite .
    Arabinose-1-13C
  • HY-125072

    Phosphatase Others
    Arabinose 1,5-diphosphate serves as an inhibitor of bisphosphatase activity.
    Arabinose 1,5-diphosphate
  • HY-N0059R

    Reference Standards Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose (Standard) is the analytical standard of D-Arabinose. This product is intended for research and analytical applications. D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose (Standard)
  • HY-W015611R

    Endogenous Metabolite Metabolic Disease
    L-(+)-Arabinose (Standard) is the analytical standard of L-(+)-Arabinose. This product is intended for research and analytical applications. L-(+)-Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion.
    L-(+)-Arabinose (Standard)
  • HY-N0059S4

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose-d2 is the deuterium labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose-d2
  • HY-N0059S

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose-13C
  • HY-N0059S6

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose-d6 is the deuterium labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose-d6
  • HY-N0059S5

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose-d5 is the deuterium labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose-d5
  • HY-N0059S2

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C-2 is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-arabinose-13C-2
  • HY-N0059S1

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C-1 is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose-13C-1
  • HY-N0059S3

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C-3 is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinose-13C-3
  • HY-42792

    Biochemical Assay Reagents Others
    5-Deoxy-L-arabinose is a biochemical assay reagent.
    5-Deoxy-L-arabinose
  • HY-W015611

    Endogenous Metabolite Metabolic Disease
    L-(+)-Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion.
    L-(+)-Arabinose
  • HY-N8116

    Others Others
    Leonloside D is a Hederagenin-derived saponin, composed of a molecule of Hederagenin and 1-3 molecules of rhamnose, glucose, or arabinose .
    Leonloside D
  • HY-E70440

    Biochemical Assay Reagents Others
    L-Arabinose isomerase is a transglutaminase. Enzymes have high catalytic efficiency, high specificity, and mild operating conditions. It can be applied in industries such as pharmaceuticals, industrial production, food manufacturing, and aquaculture .
    L-Arabinose isomerase
  • HY-W416196

    Biochemical Assay Reagents Others
    2,3,5-Tris-O-(phenylmethyl)-D-arabinose can be used in glycobiology research.
    2,3,5-Tris-O-(phenylmethyl)-D-arabinose
  • HY-167291

    Biochemical Assay Reagents Others
    D-Arabinose 5-phosphate (sodium) is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .
    D-Arabinose 5-phosphate sodium
  • HY-N7082

    Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinopyranose is a rare aldehyde pentose, and its ring-opened form is D-arabinose (HY-N0059). D-arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinopyranose
  • HY-N5102

    Others Others
    D-(+)-Fucose is a nonmetabolizable analogue of l-arabinose. D-(+)-Fucose prevents growth of Escherichia coli B/r on a mineral salts medium plus l-arabinose by inhibiting induction of the l-arabinose operon . D-fucose is a potent inducer of beta-methylgalactoside permease (MGP) .
    D-(+)-Fucose
  • HY-N7082S

    Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinopyranos- 13C5 is 13C labeled D-Arabinopyranos (HY-N7082). D-Arabinopyranose is a rare aldehyde pentose, and its ring-opened form is D-arabinose (HY-N0059). D-arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) .
    D-Arabinopyranose-13C5
  • HY-N5102R

    Others Others
    D-(+)-Fucose (Standard) is the analytical standard of D-(+)-Fucose. This product is intended for research and analytical applications. D-(+)-Fucose is a nonmetabolizable analogue of l-arabinose. D-(+)-Fucose prevents growth of Escherichia coli B/r on a mineral salts medium plus l-arabinose by inhibiting induction of the l-arabinose operon . D-fucose is a potent inducer of beta-methylgalactoside permease (MGP) .
    D-(+)-Fucose (Standard)
  • HY-134163

    4-Methylumbelliferyl alpha-L-arabinopyranoside

    Biochemical Assay Reagents Others
    4-Methylumbelliferyl α-L-arabinopyranoside (4-Methylumbelliferyl alpha-L-arabinopyranoside) is a substrate for enzymes that hydrolyze arabinose-containing substrates, such as α-L-arabinopyranoside .
    4-Methylumbelliferyl α-L-arabinopyranoside
  • HY-E70412

    Endogenous Metabolite Metabolic Disease
    Galactose 1-dehydrogenase, E.coli is a dehydrogenase expressed in E. coli. Galactose 1-dehydrogenase, E.coli catalyzes the oxidation of L-arabinose and D-galactose using NADP +/NAD + as cofactors. Galactose 1-dehydrogenase, E.coli can be used in diagnostic tests to determine total galactose content and can also serve as a biocatalyst for producing galacturonate .
    Galactose 1-dehydrogenase, E.coli
  • HY-E70412A

    Endogenous Metabolite Metabolic Disease
    Galactose 1-dehydrogenase, pseudomonas fluorescens is a dehydrogenase expressed in Pseudomonas fluorescens. Galactose 1-dehydrogenase, pseudomonas fluorescens catalyzes the oxidation of L-arabinose and D-galactose using NADP +/NAD + as a cofactor. Galactose 1-dehydrogenase, pseudomonas fluorescens can be used in diagnostic tests to measure total galactose content and can also act as a biocatalyst for producing galacturonic acid salts .
    Galactose 1-dehydrogenase, pseudomonas fluorescens
  • HY-19750
    TBA-7371
    1 Publications Verification

    Bacterial Infection
    TBA-7371 is an orally active and non-covalent inhibitor of Decaprenylphosphoryl-β-D-ribose oxidase (DprE1) of Mycobacterium tuberculosis (MIC=0.64 μg/mL). TBA-7371 can block the synthesis of arabinose in the bacterial cell wall, resulting in cell wall structural defects, thereby exerting an anti-tuberculosis effect. TBA-7371 can be used in the research of anti-tuberculosis drugs and has a synergistic bactericidal effect with Bedaquiline (HY-14881) and other drugs .
    TBA-7371

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: